BIOAVAILABILITY OF MORPHINE FROM SUPPOSITORIES

被引:16
作者
MOOLENAAR, F
VISSER, J
LEUVERMAN, A
SCHOONEN, BJM
机构
关键词
D O I
10.1016/0378-5173(88)90046-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:161 / 164
页数:4
相关论文
共 7 条
[1]  
ELLISON NM, 1984, CLIN PHARMACY, V3, P614
[2]  
LIPMAN AG, 1984, AM J HOSP PHARM, V41, P637
[3]   DRASTIC IMPROVEMENT IN THE RECTAL ABSORPTION PROFILE OF MORPHINE IN MAN [J].
MOOLENAAR, F ;
YSKA, JP ;
VISSER, J ;
MEIJER, DKF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (01) :119-121
[4]  
Schoonen A., 1976, PHARM WEEKBLAD, V111, P585
[5]   RELEASE OF DRUGS FROM FATTY SUPPOSITORY BASES .1. RELEASE MECHANISM [J].
SCHOONEN, AJM ;
MOOLENAAR, F ;
HUIZINGA, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 4 (02) :141-152
[6]   RELEASE OF DRUGS FROM FATTY SUPPOSITORY BASES .2. A RATE-LIMITING INTERFACIAL PROCESS [J].
SCHOONEN, AJM ;
MOOLENAAR, F ;
REUVERS, KA ;
HUIZINGA, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1980, 7 (01) :29-43
[7]   DETERMINATION OF MORPHINE IN CEREBROSPINAL-FLUID AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
TODD, RD ;
MULDOON, SM ;
WATSON, RL .
JOURNAL OF CHROMATOGRAPHY, 1982, 232 (01) :101-110